What question did this study set out to answer?

The aim is to discuss recent developments in cancer vaccines and how the COVID-19 pandemic has influenced this field.

February 14, 2026JAMA Oncology1 citations

The Time for Cancer Vaccines Is Now

KDKiranjit K. Dhillon LLLennard Y. W. Lee

Key Points

The aim is to discuss recent developments in cancer vaccines and how the COVID-19 pandemic has influenced this field.
Analyzed advances in cancer vaccine technology
Reviewed clinical trial results
Examined the role of AI in vaccine development
Explored the use of pandemic infrastructure for vaccine research
Identified successful clinical trial outcomes for cancer vaccines
Highlighted the potential of AI to enhance vaccine design
Demonstrated how COVID-19 frameworks can expedite vaccine deployment

Abstract

This Viewpoint discusses advances in cancer vaccines, including the use of COVID-19 pandemic–related infrastructure, clinical trial results, and harnessing artificial intelligence.

问 AI

Bookmark

View Full Paper

Cite This Study

Dhillon et al. (Thu,) studied this question.

synapsesocial.com/papers/699011712ccff479cfe58273 https://doi.org/https://doi.org/10.1001/jamaoncol.2025.6203

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

问 AI

Bookmark

View Full Paper